These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1342302)

  • 1. The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.
    Haverkate F; Thompson SG; van de Loo JC
    Ann Epidemiol; 1992 Jul; 2(4):521-4. PubMed ID: 1342302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography.
    Eur Heart J; 1993 Jan; 14(1):8-17. PubMed ID: 8432297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
    Juhan-Vague I; Thompson SG; Jespersen J
    Arterioscler Thromb; 1993 Dec; 13(12):1865-73. PubMed ID: 8241109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
    Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
    Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group.
    Haverkate F; Thompson SG; Duckert F
    Thromb Haemost; 1995 Apr; 73(4):561-7. PubMed ID: 7495059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
    Held C; Hjemdahl P; Håkan Wallén N; Björkander I; Forslund L; Wiman B; Rehnqvist N
    Atherosclerosis; 2000 Jan; 148(1):179-88. PubMed ID: 10580184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.
    Juhan-Vague I; Pyke SD; Alessi MC; Jespersen J; Haverkate F; Thompson SG
    Circulation; 1996 Nov; 94(9):2057-63. PubMed ID: 8901651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.
    Jax TW; Peters AJ; Plehn G; Schoebel FC
    Cardiovasc Diabetol; 2009 Sep; 8():48. PubMed ID: 19735543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability over time of haemostatic and other cardiovascular risk factors in patients suffering from angina pectoris. ECAT Angina Pectoris Study Group.
    Pyke SD; Thompson SG; Buchwalsky R; Kienast J
    Thromb Haemost; 1993 Nov; 70(5):743-6. PubMed ID: 8128428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.
    Daví G; Violi F; Catalano I; Giammarresi C; Putignano E; Nicolosi G; Barbagallo M; Notarbartolo A
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):41-5. PubMed ID: 1772997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.
    de Maat MP; de Bart AC; Hennis BC; Meijer P; Havelaar AC; Mulder PG; Kluft C
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1156-62. PubMed ID: 8792769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of a prothrombotic state in restenotic patients?
    Brack MJ; More RS; Pringle S; Gershlick AH
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
    Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular markers of hemostatic activation on coronary artery disease.
    Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
    Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
    Borries M; Heins M; Fischer Y; Stiegler H; Peters A; Reinauer H; Schoebel FC; Strauer BE; Leschke M
    J Am Coll Cardiol; 1999 Aug; 34(2):486-93. PubMed ID: 10440163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Markers for the prognosis of success of coronary interventions: focus on changes in fibrinolysis and hemostasis].
    Hoffmeister HM
    Herz; 2001 Apr; 26 Suppl 1():19-23. PubMed ID: 11349621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controls.
    Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Forslund L; Björkander I; Angelin B; Wiman B
    J Intern Med; 1997 Jan; 241(1):59-69. PubMed ID: 9042095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris.
    Jansson JH; Nilsson TK; Olofsson BO
    Eur Heart J; 1991 Feb; 12(2):157-61. PubMed ID: 1904350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinopeptide A and platelet factor levels in unstable angina pectoris.
    Théroux P; Latour JG; Léger-Gauthier C; De Lara J
    Circulation; 1987 Jan; 75(1):156-62. PubMed ID: 2947740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.